![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Topical |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.039.594 |
Chemical and physical data | |
Formula | C16H14N2O3 |
Molar mass | 282.299 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Bendazac (or bendazolic acid) is a nonsteroidal anti-inflammatory drug (NSAID) used for joint and muscular pain.[1]
Synthesis
Principal action is inhibition of protein denaturation.
![](https://web.archive.org/web/20220903220839im_/https://upload.wikimedia.org/wikipedia/commons/thumb/3/34/Bendazac_synthesis.svg/700px-Bendazac_synthesis.svg.png)
Bendazac synthesis: BE 699226; G. Palazzo, U.S. Patent 3,470,194 (1967, 1969 both to Francesco Angelini).
Use of chloroacetamide in the alkylation step, followed by acid hydrolysis produces bendazac (instead of benzydamine).
See also
References